Friday, June 08, 2012 12:51:00 PM
Current Activities
PharmStar is currently in negotiations with three different funding groups for full funding to get into production. These talks are very promising.
PharmStar is in discussions with another pharmaceutical company to joint venture synergistic products.
PharmStar has now fully developed line extensions to Aquaprin, including Aquaprin Cough & Cold, Aquaprin Menstrual, Aquaprin Sinus, Aquaprin Allergy, Aquaprin Children and Teenagers.
PharmStar is now evaluating a sublingual fast dissolving tablet.
PharmStar is in discussions with two additional doctors for positions on our medical advisory board. PharmStar has made three tour presentations. Since we have not had a positive response from these meetings, we are considering ending this program since the promised funding for this tour did not occur.
PharmStar is in discussions with a new Public Relations Firm with an agreement almost completed.
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM